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Edited by Maurice MontalAbstract We quantitatively measured protective antigen (PA)
binding to human cells targeted by anthrax lethal toxin (LT).
Aﬃnities were less than 50 nM for all cells, but diﬀerentiated cells
(macrophages and neutrophils) had signiﬁcantly increased PA
binding and endothelial cells demonstrated themost binding. Com-
bined with the function of such cells, this suggests that PA recep-
tors interact with the extracellular matrix and that
diﬀerentiation increases the number of PA-speciﬁc receptors,
which supports previously observed diﬀerentiation-induced LT
susceptibility. Our results quantiﬁably conﬁrm that the generality
of PA binding will complicate its use as a tumor targeting agent.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Lethal toxin (LT) and edema toxin (ET) of Bacillus anthracis
use protective antigen (PA) to deliver toxic partner proteins,
lethal factor (LF) and edema factor (EF), to the cytosol by
binding to cellular receptors [1]. PA-mediated internalization
of LF and EF occurs following PA heptamerization on the cell
surface and pH-dependent pore formation within the endo-
some (reviewed in [2]). Quantiﬁcation of the aﬃnity and num-
ber of endogenous PA-speciﬁc receptors is important for
understanding the role of PA in anthrax virulence and its po-
tential as a pharmaceutical delivery agent [3–5]. Previous stud-
ies have measured the binding aﬃnity of PA to non-human
mammalian cells [6,7] and puriﬁed receptors [8], but informa-
tion on PA binding to human cells is lacking. Although the
known PA-speciﬁc receptors, tumor endothelial marker 8
(TEM8) and capillary morphogenesis gene 2 (CMG2) [9,10],
were discovered in CHO-K1 cells and human endothelial cellsAbbreviations: ET, edema toxin; LT, lethal toxin; PA, protective
antigen; EF, edema factor; LF, lethal factor; CMG2, capillary morp-
hogenesis gene 2; TEM8, tumor endothelial marker 8; PMA, phorbol
12-myristate 13-acetate; PI, propidium iodide; MESF, mean equivalent
soluble ﬂuorescein
*Corresponding author. Fax: +1 505 665 3024.
E-mail address: graves@lanl.gov (S.W. Graves).
1 These authors contributed equally to this work.
0014-5793/$32.00  2006 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2006.06.070[6,11], the susceptibility of mouse macrophages [12], activated
monocytes [13], and platelets [14] to LT killing as well as LT
induced paralysis of neutrophils [15] suggests that PA recep-
tors are present on many cell types.
In this study, we quantiﬁed the aﬃnity and number of PA-
speciﬁc receptors on the surface of known target animal cell
lines. These studies were extended to human cell lines which
represent several phenotypes known to be targeted by anthrax;
the eﬀect of cell diﬀerentiation on the receptor parameters was
also measured. Our results are considered in light of recent
ﬁndings, which suggest a mechanism for cell type-speciﬁc sus-
ceptibility to LT based upon diﬀerential display of PA-speciﬁc
receptors; the implications of these results for recent work on
the use of PA as a mechanism for targeted drug delivery
[4,5] are also discussed.2. Materials and methods
2.1. Materials
All cell lines were obtained from the American Tissue Culture Collec-
tion (ATCC), Manassas, VA. Culture medium, supplements and phor-
bol 12-myristate 13-acetate (PMA) were from Sigma–Aldrich, St.
Louis, MO. PA was from List Biological Laboratories, Campbell CA.
Alexa Fluor 488 was from Molecular Probes, Eugene, OR. FITC-stan-
dard microspheres were from Bangs Laboratories, Fishers, IN.
2.2. Cell culture
Cells were maintained according to ATCC instructions with the
exception of CHO-K1 cells (alpha minimal essential media and 10%
FBS) and HL-60 cells (RPMI-1640 with L-glutamine and 10% FBS).
2.3. Fluorescent labeling of PA
PA was reconstituted according to manufacturer’s instructions and
labeled with 20-fold molar excess of Alexa Fluor 488 in sodium bicar-
bonate buﬀer (0.1 M, pH 8.3) for 1 h on ice in the dark, then puriﬁed
by gel ﬁltration. Fluor-to-protein ratio and relative quantum eﬃciency
were obtained as described previously [16]. Fluor-to-protein ratios
were between 1 and 2.5 to minimize steric eﬀects due to labeling.
2.4. PA binding to cells
THP-1, HL-60, and U-937 cells were diﬀerentiated into macro-
phages with PMA (50 ng/ml for 24 h) [17]. HL-60 cells were diﬀeren-
tiated into neutrophils by incubation in 1.5% dimethyl sulfoxide for
ﬁve days [18]. Adherent cells were harvested by Accutase treatment
after rinsing with PBS and washed twice with their respective serum-
free, phenol red-free medium with 1 mM MgCl2, 1% BSA, penicillin,
and streptomycin. Cells (1 · 106 cells/ml) were incubated with
Alexa488-PA for 2 h on ice in the dark, washed twice and re-suspended
in media with 1 lg/ml propidium iodide (PI) to identify non-viable
cells. Surface localization of PA was conﬁrmed by visualization of
PA bound to CHO-K1 cells at 63· magniﬁcation on a Zeiss (Chester,
VA) confocal microscope (data not shown).ation of European Biochemical Societies.
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Alexa488-PA ﬂuorescence between cells pre-incubated with and with-
out unlabeled PA (100-fold molar excess for 1 h on ice). Alternatively,
speciﬁc binding was measured by washing the cells in media with 1%
BSA after incubation with Alexa488-PA. The results for receptor aﬃn-
ity and number for the two methods were equivalent (data not shown);
speciﬁc binding reported in this work was determined using washed
cells.
2.5. Flow cytometry
Flow cytometric analysis was performed on a FACSCalibur
(Becton-Dickinson, San Jose, CA). Alexa488 (530/30 nm band pass
ﬁlter) and PI (670 nm long pass ﬁlter) ﬂuorescence was collected
following 488 nm excitation. Cells were gated based on light scat-
ter, and PI-positive cells were excluded from analyzed cell popula-
tions (3000 cells).Fig. 1. Representative Alexa488-PA binding curve for CHO-K1 cells.
Data from a single typical experiment were ﬁt with a hyperbola; mean
receptor number 86588, KD 6.57 nM.
Fig. 2. (a) Mean receptor number per cell for all cell types studied. (b)
Undiﬀerentiated cells are shown in black; macrophages in dark gray; neutro2.6. Data analysis
Mean ﬂuorescence intensity of the cell population was converted
to mean equivalent soluble ﬂuorescein (MESF) using a standard
curve generated with FITC-standard microspheres [19]. MESF was
converted to equivalent mean number of Alexa488-PA molecules
bound per cell as previously described [16] and plotted as a function
of increasing Alexa488-PA concentration. Data were ﬁt to a hyper-
bolic function [y = (A Æ x)/(KD + x) + y0] using SigmaPlot version 9
(Systat Software, Richmond, CA) to extract ﬁtted values via non-
linear regression. The amplitude of the curve, A, is an estimate of
the amount of bound PA molecules per cell. Receptor number
was estimated using the expected 1:1 stoichiometry of binding be-
tween PA and its known receptors [1]. The KD is the equilibrium
dissociation constant, which is also the value of x when y = 1/2ymax.
In this curve, y0 accounts for the initial cellular autoﬂuorescence
values prior to addition of ﬂuorescent PA. Statistical analysis of
the receptor number and KD data was done by two-tailed Student’s
t test after veriﬁcation of homoscedasticity using the F distribution
(data not shown).3. Results
3.1. Speciﬁc binding of PA to the surface of mammalian cells
Alexa488-PA (0–250 nM) was bound to CHO-K1 cells as
described. Data from a typical experiment are shown in
Fig. 1; the graph demonstrates speciﬁc and saturable binding
of PA to these cells, as non-speciﬁc binding would be expected
to show a linear trend with no saturation. The mean receptor
number for all cell types studied is graphically represented in
Fig. 2a and the mean KD in Fig. 2b. The other non-human
mammalian cell line analyzed, J774A.1 murine macrophages,
also showed speciﬁc and saturable PA binding (data not
shown).
Using the methods described above, we measured the recep-
tor number and KD for human target cell lines: HUV-EC-C,
THP-1, HL-60, and U-937 (Fig. 2). The binding curves forMean KD for all cell types studied. Data shown are means ± S.D.
phils in light gray; endothelial and epithelial cells in white.
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(data not shown) with minimum R2 values of 0.9839 (range
0.9839–0.9998, mean 0.9980). All human and non-human cell
types showed mean KD values in the low nanomolar range
(range 5.8–33.3 nM). HUV-EC-C endothelial cells showed
the highest amount of speciﬁc binding – with a high degree
of statistical signiﬁcance – of the cell lines studied here (P val-
ues < 0.006 for comparison to all other cells).3.2. Cell diﬀerentiation increases the number of PA-speciﬁc
receptors
We diﬀerentiated HL-60 promyelocytes into macrophage
and neutrophil phenotypes and obtained PA binding curves
as described above. Results from three typical experiments
are shown in Fig. 3. Repeat experiments conﬁrmed that neu-
trophils demonstrated a nearly 4-fold increase in receptor
number from the undiﬀerentiated promyelocytes while macro-
phages demonstrated a 2-fold increase (Fig. 2). A 2-fold in-
crease in receptor number was also observed when THP-1
and U-937 monocytes were diﬀerentiated into their macro-
phage phenotypes (Fig. 2). Multiple experiments to measure
both the number of receptors bound and the KD of binding
were used to provide estimates of the statistical signiﬁcance
of these measurements (Table 1). HL-60 cells also showed a
statistically signiﬁcant decrease in binding aﬃnity upon diﬀer-
entiation into macrophages (Table 1), a trend which is not mir-
rored in the THP-1 cells but perhaps might be occurring in the
U-937 monocytes (Fig. 2b).Fig. 3. Representative Alexa488-PA binding curves for undiﬀerenti-
ated and diﬀerentiated HL-60 cells. Speciﬁc binding of PA to HL-60
neutrophils (ﬁlled circles), HL-60 macrophages (open circles) and
HL-60 promyelocytes (ﬁlled triangles) in three separate typical
experiments.
Table 1
Statistical analysis of diﬀerences in receptor number and KD within diﬀerent
Compared cell lines
HL-60 promyelocytes vs. HL-60 macrophages
HL-60 promyelocytes vs. HL-60 neutrophils
HL-60 macrophages vs. HL-60 neutrophils
THP-1 monocytes vs. THP-1 macrophages
U-937 monocytes vs. U-937 macrophages
P values are result of two-tailed Student’s t test. Data are results of four inde
experiments).4. Discussion
We have measured the aﬃnity and number of PA-speciﬁc
receptors on the surface of a variety of mammalian cell types.
Binding of PA to all human target cell types was speciﬁc and
most cell types had similar meanKD values, suggesting the pres-
ence of a similar class of PA receptors. This work indicates that
endogenous PA receptors on the tested cell types bind PA with
aﬃnities in the low nanomolar range in the presence of Mg2+
(Fig. 2b). This is in contrast to in vitro measurements showing
that CMG2 has picomolar aﬃnity for PA in the presence of
Mg2+ ions [8], but is consistent with initial PA binding
experiments conducted on CHO-K1 cells using radiolabeling
techniques [6]. Our receptor numbers are higher for both
CHO-K1 and J774A.1 cells as compared to other approaches
[6,7]; this could be due to variations in cell culture conditions
and experimental methods. Beyond experimental variability,
variation in the number of PA-speciﬁc receptors could be due
to increased expression of PA-speciﬁc receptors on certain cell
types. Alternatively, it is also possible that PA receptors func-
tion in similar fashion to a integrins, which can alter their
ligand binding aﬃnities by many orders of magnitude via a con-
formational change in the I domain [20]. This is plausible, as the
known receptors for PA (TEM8 and CMG2) have a high de-
gree of homology to the I domains found in some a integrins
[1]. Therefore, the change in PA-speciﬁc receptor number could
be a result of conformational changes of very low aﬃnity-state
(eﬀectively no aﬃnity) receptors to high aﬃnity-state PA-
speciﬁc receptors. Regardless of the mechanism by which recep-
tor number varies, among the human target cell lines studied,
statistical analysis reveals several correlations between cell type
and increased numbers of PA-speciﬁc receptors.
First, HUV-EC-C endothelial cells have the highest amount
of speciﬁc binding of any cell type we studied. Recent studies
suggest that LT attacks the endothelial barrier to achieve vas-
cular permeability [21]. We postulate that the increased num-
ber of PA-speciﬁc receptors on endothelial cells provides a
biochemical mechanism to support the theory that the vascular
endothelium, which is continuously exposed to the blood
stream, is a primary target of PA binding and subsequent toxin
delivery [22,23]. Increased receptor number on endothelial cells
also supports recent cell viability studies indicating that LT
targets the microvascular endothelial cells of the human lung
after anthrax spore inhalation [24].
Second, diﬀerentiation from monocytes to mature cell types
such as neutrophils and macrophages results in a statistically
signiﬁcant increase in PA-speciﬁc binding (Table 1). The vari-
ance in the HL-60 macrophage population limits the P values
to 0.0782 and 0.1375 for some cell-to-cell comparisons (promy-
elocytes vs. macrophages and macrophages vs. neutrophils,iated cell types
P value
Receptor # KD
0.0782 0.0005
0.0006 0.0372
0.1375 0.0015
0.0022 0.8505
0.0579 0.0850
pendent experiments for each cell type, except U-937 monocytes (three
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creased binding upon diﬀerentiation. As neutrophils and mac-
rophages interact with the extracellular matrix during
extravasation and endothelial cells are themselves adherent,
our data are consistent with previous observations that PA
receptors have possible involvement in extracellular matrix
interactions [11,25,26]. One study suggests that diﬀerentiation
of monocytes to macrophages confers susceptibility to LT-
mediated death despite internalization of LF by both cell
types, and the authors provide several possibilities to explain
the lack of cell killing in undiﬀerentiated cells [27]. It is possible
that such observations could arise from an increase in the
number of PA-speciﬁc receptors present on diﬀerentiated cells,
resulting in binding of larger amounts of PA, greater uptake of
toxin, and consequently more intracellular LF to initiate multi-
ple downstream eﬀects. This model is further supported by
studies demonstrating that CHO-K1 cells expressing TEM8
or CMG2 receptors at higher than endogenous levels were
more susceptible to killing by N-terminal LF–diphtheria toxin
A chain [10].
In summary, this is the ﬁrst rigorous quantitative ﬂow
cytometry study to determine the prevalence of natural PA
receptors across a range of potential target cell types for an-
thrax LT. Experiments are underway to determine the identity
of the PA-speciﬁc receptors expressed on the human cell lines
studied here. However, we have quantitatively conﬁrmed that
a variety of cell types are able to speciﬁcally bind PA and that
cells targeted by LT have signiﬁcantly increased PA binding,
presumably resulting from greater display of PA-speciﬁc recep-
tors. Furthermore, the generality of PA binding needs to be
considered in studies that use PA as a cell speciﬁc delivery vehi-
cle for cancer therapies [4], which supports the extensive eﬀorts
to create engineered PA molecules (bearing altered protease
cleavage sites) to speciﬁcally target tumor cells with chemo-
therapeutic agents [5].
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